Chronic kidney disease: Classification of CKD should be about more than prognosis

Nature Reviews Nephrology

Volumn 9, Issue 12, 2013, Pages 697-698

  Rule, Andrew D ^a   Glassock, Richard J ^b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYSTATIN C; D DIMER;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL PRACTICE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIET; DISEASE CLASSIFICATION; FRAMINGHAM RISK SCORE; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOMODULATION; KIDNEY FAILURE; LUNG EMBOLISM; MORTALITY; OBESITY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; SHORT SURVEY;

BIOLOGICAL MARKERS; CREATININE; CYSTATIN C; GLOMERULAR FILTRATION RATE; HUMANS; PROGNOSIS; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT;

EID: 84888873777     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2013.222     Document Type: Short Survey

References (10)

1. Kidney Disease Outcome Quality Initiative (K/DOQI). K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am. J. Kidney Dis. 39, S1-S246 (2002)
2. Eckardt, K. U., Berns, J. S., Rocco, M. V. & Kasiske, B. L. Definition and classification of CKD: the debate should be about patient prognosis - a position statement from KDOQI and KDIGO. Am. J. Kidney Dis. 53, 915-920 (2009)
3. Matsushita, K. et al. Comparison of risk prediction using the CKD-EPI Equation and the MDRD Study Equation for estimated glomerular filtration rate. JAMA 307, 1941-1951 (2012)
4. Peralta, C. A. et al. Cystatin C identifies chronic kidney disease patients at higher risk for complications. J. Am. Soc. Nephrol. 22, 147-155 (2011)
5. Kidney Disease Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 3, 1-150 (2013)
6. Shlipak, M. G. et al. Cystatin C versus creatinine in determining risk based on kidney function. N. Engl. J. Med. 369, 932-943 (2013)
7. Lafarge, J. C., Naour, N., Clement, K. & Guerre-Millo, M. Cathepsins and cystatin C in atherosclerosis and obesity. Biochimie 92, 1580-1586 (2010)
8. Staun-Ram, E. & Miller, A. Cathepsins (S and B) and their inhibitor cystatin C in immune cells: modulation by interferon-? and role played in cell migration. J. Neuroimmunol. 232, 200-206 (2011)
9. Rule, A. D. & Glassock, R. J. GFR estimating equations: getting closer to the truth? Clin. J. Am. Soc. Nephrol. 8, 1414-1420 (2013)
10. Rule, A. D., Bailey, K. R., Lieske, J. C., Peyser, P. A. & Turner, S. T. Estimating the glomerular filtration rate from serum creatinine is better than from cystatin C for evaluating risk factors associated with chronic kidney disease. Kidney Int. 83, 1169-1176 (2013)